{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:09:26Z","timestamp":1758085766014,"version":"3.44.0"},"reference-count":20,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,9,1]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Calcineurin inhibitors (CNIs) are essential medications for many people living with solid-organ transplants. CNI therapy helps prevent organ transplant rejection, though it requires monitoring to ensure efficacy and safety. Here we report a case of a young kidney transplant recipient who developed a severe and debilitating complication of CNI therapy that resolved following CNI dose reduction. CNI-induced pain syndrome (CIPS) may affect as many as 1 in 20 people treated with CNIs, including many of the 62\u2009900 people in the United Kingdom who require CNI therapy following organ transplantation. Clinical presentation, severity and duration are variable, though the condition is often associated with elevated serum alkaline phosphatase levels. Limited awareness of CIPS, compounded by the potential for severe symptoms to develop even when CNI blood levels are within the standard therapeutic range, risks delayed recognition and significant patient suffering, as this case report highlights. Appropriate clinical suspicion of CIPS is thus imperative to limit patient harm and resource use associated with this under-recognised and potentially serious condition.<\/jats:p>","DOI":"10.1136\/bcr-2025-266427","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:40:26Z","timestamp":1757990426000},"page":"e266427","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Debilitating musculoskeletal pain after solid organ transplantation: an under-recognised and serious condition associated with common immunosuppressive drug therapy"],"prefix":"10.1136","volume":"18","author":[{"given":"Simon","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Renal Medicine, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheamus","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Department of Radiology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5979-4664","authenticated-orcid":false,"given":"Jonathan S","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK"},{"name":"School of Health and Life Sciences, Teesside University, Middlesbrough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2025091519401224000_18.9.e266427.1","unstructured":"Activity report 2024\/2025 organ and tissue donation and transplantation. NHS Blood and Transplant; 2025.10\u20131."},{"key":"2025091519401224000_18.9.e266427.2","unstructured":"OPTN\/srtr 2023 annual data report. United States Organ Transplantation; 2023.35."},{"key":"2025091519401224000_18.9.e266427.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.08.006"},{"key":"2025091519401224000_18.9.e266427.4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.kint.2021.03.041","article-title":"The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis","volume":"100","author":"Lambourg","year":"2021","journal-title":"Kidney Int"},{"key":"2025091519401224000_18.9.e266427.5","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-15-6","article-title":"Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease","volume":"15","author":"Hsu","year":"2014","journal-title":"BMC Nephrol"},{"key":"2025091519401224000_18.9.e266427.6","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/90.5.359"},{"key":"2025091519401224000_18.9.e266427.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)70118-X"},{"key":"2025091519401224000_18.9.e266427.8","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57060525","article-title":"Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant\u2019s Recipients: A Systematic Review","volume":"57","author":"Hassan","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"2025091519401224000_18.9.e266427.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2001.tb00004.x"},{"key":"2025091519401224000_18.9.e266427.10","unstructured":"Matthews AH , Davis DD , Fish MJ , et al . Avascular necrosis. In: Anonymous. StatPearls. Treasure Island (FL): StatPearls Publishing, 2025."},{"key":"2025091519401224000_18.9.e266427.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2003.10.067"},{"key":"2025091519401224000_18.9.e266427.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2008.00668.x"},{"key":"2025091519401224000_18.9.e266427.13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-11-199412010-00007"},{"key":"2025091519401224000_18.9.e266427.14","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.20512.x"},{"key":"2025091519401224000_18.9.e266427.15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001833"},{"key":"2025091519401224000_18.9.e266427.16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clinimag.2018.10.022","article-title":"Calcineurin-inhibitor induced pain syndrome - Magnetic resonance imaging and scintigraphic findings illustrated through two cases","volume":"53","author":"Chadha","year":"2019","journal-title":"Clin Imaging"},{"key":"2025091519401224000_18.9.e266427.17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/1529-0131(199803)41:3<565::AID-ART29>3.0.CO;2-5","article-title":"A potential mechanism of cyclosporine-associated bone pain: comment on the radiologic vignette by Stone et al","volume":"41","author":"O\u2019Neill","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2025091519401224000_18.9.e266427.18","doi-asserted-by":"publisher","DOI":"10.1016\/0309-1651(91)90096-2"},{"key":"2025091519401224000_18.9.e266427.19","unstructured":"Safarini OA , Keshavamurthy C , Patel P . Calcineurin inhibitors. In: Anonymous. StatPearls. Treasure Island (FL): StatPearls Publishing, 2025."},{"key":"2025091519401224000_18.9.e266427.20","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1097\/MIB.0000000000000130","article-title":"Role in calcineurin inhibitors for inflammatory bowel disease in the biologics era: when and how to use","volume":"20","author":"Nakase","year":"2014","journal-title":"Inflamm Bowel Dis"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-266427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:40:31Z","timestamp":1757990431000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-266427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,15]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bcr-2025-266427"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-266427","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}